Matica Biotechnology, the US contract development and manufacturing organization subsidiary of CHA Biotech, has partnered ...

Creative Biolabs is strengthening its lipid-based delivery portfolio with enhanced lipid nanoparticle (LNP) and liposome engineering capabilities designed to support the growing demand for RNA ...

Applied StemCell & RoosterBio enter strategic partnership to develop and commercialize scalable iPSC-based bioprocess solutions: Milpitas, California Thursday, July 9, 2026, 17:00 ...

NTxscribe FLEX is a flexible, purpose-built system that gives researchers and development teams direct control over their RNA production process.

Matica Biotechnology, Inc. ("Matica Bio"), a viral vector contract development and manufacturing organization (CDMO), is ...

Kusumgar IPO GMP Day 2: The IPO received a solid response on Day 1, with the issue subscribed 3.45 times against the 1.14 ...

Next-generation instruments improve rare-cell detection, sterility control, biosafety, and throughput for translational ...

Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...

Leading Korean biotech specialists have joined forces to sharply cut the time needed to develop and commercialize cell and ...

Matica Biotechnology, a US subsidiary of Chabiotech, has joined forces with American biotech firm Vaxdom to co-develop an ...

MeiraGTx to receive up to $375 million in non-dilutive cash and up to $25 million in equity investmentFollowing regulatory approval, Oberland ...